Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

524 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Lessons from phase III clinical trials on anti-VEGF therapy for cancer.
Jain RK, Duda DG, Clark JW, Loeffler JS. Jain RK, et al. Among authors: clark jw. Nat Clin Pract Oncol. 2006 Jan;3(1):24-40. doi: 10.1038/ncponc0403. Nat Clin Pract Oncol. 2006. PMID: 16407877 Review.
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies.
Ryan DP, Supko JG, Eder JP, Seiden MV, Demetri G, Lynch TJ, Fischman AJ, Davis J, Jimeno J, Clark JW. Ryan DP, et al. Among authors: clark jw. Clin Cancer Res. 2001 Feb;7(2):231-42. Clin Cancer Res. 2001. PMID: 11234874 Clinical Trial.
A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumors.
Seiden MV, Ng SW, Supko JG, Ryan DP, Clark JW, Lynch T, Huang KC, Kwiatkowski D, Skarin A, Eder JP Jr. Seiden MV, et al. Among authors: clark jw. Clin Cancer Res. 2002 Mar;8(3):691-7. Clin Cancer Res. 2002. PMID: 11895897 Clinical Trial.
Phase II study of paclitaxel and carboplatin for malignant melanoma.
Hodi FS, Soiffer RJ, Clark J, Finkelstein DM, Haluska FG. Hodi FS, et al. Among authors: clark j. Am J Clin Oncol. 2002 Jun;25(3):283-6. doi: 10.1097/00000421-200206000-00016. Am J Clin Oncol. 2002. PMID: 12040289 Clinical Trial.
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma.
Fuchs CS, Clark JW, Ryan DP, Kulke MH, Kim H, Earle CC, Vincitore M, Mayer RJ, Stuart KE. Fuchs CS, et al. Among authors: clark jw. Cancer. 2002 Jun 15;94(12):3186-91. doi: 10.1002/cncr.10607. Cancer. 2002. PMID: 12115351
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.
Eder JP Jr, Supko JG, Clark JW, Puchalski TA, Garcia-Carbonero R, Ryan DP, Shulman LN, Proper J, Kirvan M, Rattner B, Connors S, Keogan MT, Janicek MJ, Fogler WE, Schnipper L, Kinchla N, Sidor C, Phillips E, Folkman J, Kufe DW. Eder JP Jr, et al. Among authors: clark jw. J Clin Oncol. 2002 Sep 15;20(18):3772-84. doi: 10.1200/JCO.2002.02.082. J Clin Oncol. 2002. PMID: 12228197 Clinical Trial.
A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors.
Michaelson MD, Ryan DP, Fuchs CS, Supko JG, Garcia-Carbonero R, Paul Eder J, Clark JW. Michaelson MD, et al. Among authors: clark jw. Cancer. 2003 Jan 1;97(1):148-54. doi: 10.1002/cncr.11038. Cancer. 2003. PMID: 12491516 Clinical Trial.
Using "rationally designed drugs" rationally.
Brugarolas J, Clark JW, Chabner B. Brugarolas J, et al. Among authors: clark jw. Lancet. 2003 May 24;361(9371):1758-9. doi: 10.1016/S0140-6736(03)13446-0. Lancet. 2003. PMID: 12781531 No abstract available.
Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer.
Ramanathan RK, Clark JW, Kemeny NE, Lenz HJ, Gococo KO, Haller DG, Mitchell EP, Kardinal CG. Ramanathan RK, et al. Among authors: clark jw. J Clin Oncol. 2003 Aug 1;21(15):2904-11. doi: 10.1200/JCO.2003.11.045. J Clin Oncol. 2003. PMID: 12885808
Combined modality therapy for rectal and colon cancer.
Chawla AK, Kachnic LA, Clark JW, Willett CG. Chawla AK, et al. Among authors: clark jw. Semin Oncol. 2003 Aug;30(4 Suppl 9):101-12. doi: 10.1016/s0093-7754(03)00276-8. Semin Oncol. 2003. PMID: 12908141 Review.
524 results
Jump to page